A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States
Authors:
- 12 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (1) , 73-79
Abstract
Mycoplasma genitalium can result in pelvic inflammatory disease and adverse pregnancy outcomes. We analyzed data collected from a prospective study of asymptomatic bacterial vaginosis (BV) to determine the natural history of M. genitalium. Women aged 15–25 years, with asymptomatic BV and ≥2 risk factors for sexually transmitted infection were recruited from 10 sites throughout the United States. Vaginal swab samples were collected at enrollment and through home-based testing every 2 months over 12 months. M. genitalium nucleic acid amplification testing was performed for M. genitalium using transcription-mediated assays (Hologic). The prevalence, incidence, and persistence of M. genitalium, defined as all positive specimens during follow-up, were estimated with 95% confidence intervals (CIs). Adjusted odds ratios (AOR) were calculated using logistic and Poisson regression to evaluate participant characteristics associated with M. genitalium infection. Among 1139 women, 233 were M. genitalium positive, for a prevalence of 20.5% (95% CI, 18.2%–22.9%); 42 of 204 had persistent M. genitalium (20.6%). Among 801 M. genitalium–negative women at baseline, the M. genitalium incidence was 36.6 per 100 person-years (95% CI, 32.4–41.3). Black race (AOR, 1.92; 95% CI, 1.09–3.38), age ≤21 years (1.40; 1.03–1.91), and prior pregnancy (1.36; 1.00–1.85) were associated with prevalent M. genitalium; only black race was associated with incident M. genitalium (P = .03). We identified high rates of prevalent, incident, and persistent M. genitalium infections among young, high-risk women with asymptomatic BV, supporting the need for clinical trials to evaluate the impact of M. genitalium screening on female reproductive health outcomes.Keywords
Funding Information
- Division of Microbiology and Infectious Diseases
- National Institute of Allergy and Infectious Diseases (HHSN26620040073C)
- Microbiology Core Laboratory of the Southeastern Sexually Transmitted Infections Cooperative Research Center (U19-AI031496)
This publication has 34 references indexed in Scilit:
- Persistent Mycoplasma genitalium Infection of Human Endocervical Epithelial Cells Elicits Chronic Inflammatory Cytokine SecretionInfection and Immunity, 2012
- The association between Mycoplasma genitalium and HIV-1 acquisition in African womenAIDS, 2012
- Mycoplasma genitalium: An Emerging Cause of Sexually Transmitted Disease in WomenPLOS Pathogens, 2011
- Comprehensive Assessment of Sociodemographic and Behavioral Risk Factors for Mycoplasma genitalium Infection in WomenSexually Transmitted Diseases, 2010
- IsMycoplasma genitaliumin Women the “New Chlamydia?” A Community‐Based Prospective Cohort StudyClinical Infectious Diseases, 2010
- Correlates of Cervical Mycoplasma genitalium and Risk of Preterm Birth Among Peruvian WomenSexually Transmitted Diseases, 2010
- Mycoplasma genitalium as a Contributor to the Multiple Etiologies of Cervicitis in Women Attending Sexually Transmitted Disease ClinicsSexually Transmitted Diseases, 2009
- Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory diseaseSexually Transmitted Infections, 2008
- Mycoplasma genitalium Infection and Persistence in a Cohort of Female Sex Workers in Nairobi, KenyaSexually Transmitted Diseases, 2007
- Mucopurulent Cervicitis andMycoplasma genitaliumThe Journal of Infectious Diseases, 2003